SPI Pharma is entering a new chapter with a refreshed brand identity designed to sharpen its position as a formulation partner to pharmaceutical and nutraceutical companies.
The global developer of excipients, drug delivery technologies, vaccine adjuvants and antacid actives has unveiled a new visual identity, brand voice and tagline: “Let's solve it together.”
The rebrand is aimed at reflecting SPI Pharma’s evolution and its focus on helping customers tackle increasingly complex formulation challenges through scientific expertise, innovation and collaboration.
Freek Snieders, CEO of SPI Pharma, said: "This is more than a new look for SPI Pharma. It represents the next chapter in our evolution as a company and reflects our ambition for the future. As our customers navigate increasingly complex formulation challenges, we are focused on being more than a supplier.
"We aspire to be a trusted partner, bringing together scientific expertise, innovative solutions, and deep collaboration to help customers develop better products and improve the lives of patients around the world. Our new brand captures the energy, confidence, and forward momentum of SPI Pharma as we continue to grow alongside our customers."
SPI Pharma said the new identity is anchored in its purpose of improving the quality of people’s lives, linking its scientific and technological capabilities to the patients ultimately served by products developed using its ingredients and technologies.
The new brand rollout will extend across the company’s digital channels, customer communications and industry events. Packaging and other materials will transition as part of normal update cycles.
SPI Pharma said the rebrand will not affect product performance, quality systems, specifications or regulatory documentation.
With more than 75 years of industry experience, SPI Pharma provides functional excipients, patient-friendly dosage forms, taste-masking technologies, drug delivery systems, vaccine adjuvants, antacid actives and development support spanning concept development through commercialization.
